News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,439 Results
Type
Article (3584)
Company Profile (13)
Press Release (52842)
Section
Business (21382)
Career Advice (66)
Deals (3753)
Drug Delivery (10)
Drug Development (4086)
Employer Resources (12)
FDA (825)
Job Trends (1054)
News (29004)
Policy (1306)
Tag
2024 BioCapital Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
Academia (238)
Allergies (3)
Alliances (5142)
ALS (3)
Alzheimer's disease (118)
Antibody-drug conjugate (ADC) (6)
Approvals (824)
Artificial intelligence (36)
Autoimmune disease (1)
Bankruptcy (32)
Best Places to Work (749)
BIOSECURE Act (2)
Biosimilars (6)
Biotechnology (13)
Bladder cancer (4)
Brain cancer (1)
Breast cancer (12)
Cancer (107)
Cardiovascular disease (8)
Career advice (59)
Career pathing (3)
CAR-T (12)
Cell therapy (31)
Clinical research (3104)
Collaboration (68)
Compensation (2)
Complete response letters (1)
COVID-19 (158)
CRISPR (2)
C-suite (32)
Cystic fibrosis (14)
Data (106)
Denatured (2)
Depression (4)
Diabetes (11)
Diagnostics (574)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (16)
Drug pricing (11)
Duchenne muscular dystrophy (3)
Earnings (4269)
Editorial (4)
Employer resources (10)
Events (5189)
Executive appointments (100)
FDA (881)
Featured Employer (2)
Friedreich's ataxia (1)
Funding (311)
Gene editing (7)
Generative AI (3)
Gene therapy (22)
GLP-1 (64)
Government (124)
Guidances (4)
Healthcare (1260)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (9)
Indications (1)
Infectious disease (166)
Inflammatory bowel disease (12)
Inflation Reduction Act (4)
Influenza (1)
Intellectual property (8)
Interviews (5)
IPO (1751)
IRA (8)
Job creations (316)
Job search strategy (57)
Labor market (4)
Layoffs (31)
Leadership (1)
Legal (273)
Liver cancer (3)
Lung cancer (15)
Lymphoma (5)
Machine learning (1)
Management (4)
Manufacturing (23)
MASH (6)
Medical device (1258)
Medtech (1260)
Mergers & acquisitions (2051)
Metabolic disorders (52)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (8)
Neuropsychiatric disorders (1)
Neuroscience (147)
NextGen: Class of 2025 (961)
Non-profit (289)
Northern California (196)
Now hiring (1)
Obesity (35)
Opinion (47)
Ovarian cancer (3)
Pain (6)
Pancreatic cancer (1)
Parkinson's disease (8)
Partnered (3)
Patents (7)
Patient recruitment (8)
Peanut (3)
People (8688)
Pharmaceutical (4)
Phase I (1055)
Phase II (1438)
Phase III (873)
Pipeline (45)
Podcasts (5)
Policy (12)
Postmarket research (95)
Preclinical (574)
Press Release (6)
Prostate cancer (5)
Psychedelics (2)
Radiopharmaceuticals (25)
Rare diseases (31)
Real estate (574)
Recruiting (5)
Regulatory (981)
Reports (3)
Research institute (165)
Resumes & cover letters (9)
Schizophrenia (3)
Series A (87)
Series B (59)
Service/supplier (1)
Sickle cell disease (1)
Southern California (144)
Special edition (2)
Sponsored (1)
Startups (2167)
Supply chain (4)
The Weekly (3)
United States (1286)
Vaccines (25)
Venture capitalists (32)
Webinars (4)
Weight loss (18)
Women's health (2)
Date
Today (10)
Last 7 days (46)
Last 30 days (200)
Last 365 days (2786)
2025 (535)
2024 (2915)
2023 (3096)
2022 (5518)
2021 (4844)
2020 (4668)
2019 (4324)
2018 (3463)
2017 (3031)
2016 (2524)
2015 (2906)
2014 (2097)
2013 (1739)
2012 (1852)
2011 (2066)
2010 (2168)
Location
Africa (63)
Alabama (5)
Alaska (2)
Arizona (10)
Arkansas (4)
Asia (3967)
Australia (478)
California (434)
Canada (403)
China (33)
Colorado (12)
Connecticut (22)
Delaware (5)
Europe (8108)
Florida (28)
Georgia (14)
Idaho (5)
Illinois (40)
India (5)
Indiana (18)
Japan (17)
Kansas (7)
Kentucky (1)
Louisiana (4)
Maine (6)
Maryland (38)
Massachusetts (258)
Michigan (8)
Minnesota (12)
Missouri (8)
Nevada (1)
New Hampshire (4)
New Jersey (63)
New Mexico (4)
New York (94)
North Carolina (52)
Northern California (196)
Ohio (22)
Oklahoma (2)
Oregon (2)
Pennsylvania (41)
Puerto Rico (3)
South America (96)
South Carolina (1)
Southern California (144)
Tennessee (5)
Texas (55)
Utah (12)
Virginia (8)
Washington D.C. (1)
Washington State (24)
Wisconsin (5)
56,439 Results for "versant ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Startups
Versant Launches Fourth Obesity Startup Helicore to Improve Weight Loss Quality
Versant Ventures continues to invest in the increasingly competitive obesity space, this time launching Helicore with $65 million and a GIP-targeting asset intended to induce higher-quality weight loss.
January 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Versant Ventures Unveils Pep2Tango Therapeutics Inc.
November 21, 2024
·
4 min read
Business
Novartis, Versant Launch RNA Kidney Medicines—Focused Borealis
Looking to build on the success of Chinook Therapeutics, founded by Versant in 2019 and acquired by Novartis last year, the companies on Thursday launched Borealis Biosciences with $150 million in funding to develop RNA therapeutics for kidney diseases.
August 22, 2024
·
2 min read
·
Kate Goodwin
Business
AstraZeneca Snags Option to Buy Versant’s New Obesity Biotech SixPeaks
SixPeaks Bio emerged from stealth Wednesday with up to $110 million, a deal with AstraZeneca and plans to take weight-loss candidates designed to preserve muscle mass toward the clinic.
May 22, 2024
·
2 min read
·
Nick Paul Taylor
Lone Star Bio
Versant Diagnostics Partners with Dahl-Chase Pathology and Diagnostic Groups
Versant Diagnostics announced its collaboration with Bangor, Maine-based Dahl-Chase Pathology Associates and Dahl-Chase Diagnostic Services.
October 23, 2023
·
2 min read
Versant Ventures Launches Vector BioPharma AG
Versant Ventures today announced the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid of viral genes.
August 10, 2022
·
5 min read
Business
Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies
AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs.
July 27, 2022
·
6 min read
Deals
Versant Ventures to File Early Warning Report in Respect of Repare Therapeutics Inc.
Versant Ventures today announced it will file an early warning report with respect to the ownership of securities in Repare Therapeutics Inc.
June 6, 2022
·
4 min read
Business
Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A
Today, Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies.
April 13, 2022
·
7 min read
Business
Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases
With Versant Ventures as a founding investor, Santa Ana Bio emerged from stealth Thursday with $168 million in combined Series A and B funding to support plans to have two programs in the clinic by next year.
June 13, 2024
·
2 min read
·
Tyler Patchen
1 of 5,644
Next
